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Abstract 
Metabolic engineering was formally defined more than two decades ago (Bailey, 1991) and it is now an 
established discipline. Metabolic engineering is generally defined as the directed improvement of 
product formation or cellular properties through the modification of specific biochemical reactions or the 
introduction of new ones with the use of recombinant DNA technology (Bailey, 1991; Stephanopoulos 
et al. 1998). Therefore, the analysis and engineering/synthesis of metabolic pathways is of central 
importance to metabolic engineering. The analytical part uses a number of experimental and modeling 
techniques for the systematic study of cellular responses (in terms of RNA, protein and metabolite 
levels, metabolic fluxes, etc.) to genetic and environmental perturbations. This facilitates a rational 
design of metabolic modifications, which are implemented using recombinant DNA technology. Both, 
the analysis and the synthesis of metabolic pathways will be covered in this review. Recent efforts on 
the engineering of fermentative and biosynthetic pathways for biofuel production in Escherichia coli, as 
well as those enabling the utilization of novel feedstocks, will be highlighted. 
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SYSTEM-LEVEL ANALYTICAL AND SYNTHETIC TOOLS IN THE METABOLIC ENGINEERING 
TOOLBOX 
Given the emphasis that metabolic engineering places on a system-level approach to analyze and 
engineer metabolism, several genome-wide techniques have been extensively used to analyze the 
metabolism of Escherichia coli and support engineering efforts (Figure 1). Below some of these 
analytical and synthetic tools in the metabolic engineering toolbox are presented. 
Metabolic engineering undoubtedly benefits from traditional techniques that enable engineering and de 
novo synthesis of promoters, ribosome binding sites and entire coding regions, thus allowing 
modulation of both expression level and activity of target proteins/enzymes. However, new tools that 
enable genome engineering and system-wide identification of genes that confer target traits are very 
useful (Boyle and Gill, 2012). These emerging techniques include multiscale analysis of library 
enrichment (SCALEs) (Lynch et al. 2007), trackable multiplex engineering (TRMR) (Warner et al. 
2010), coexisting/coexpressing genomic libraries (CoGeL) (Nicolaou et al. 2011), genome-scale 
analysis of library sorting (GALibSo) (Stadlmayr et al. 2010), multiplex automated genome engineering 
(MAGE) (Wang et al. 2009), conjugative assembly genome engineering (CAGE) (Isaacs et al. 2011), 
and global transcription machinery engineering (gTME) (Alper and Stephanopoulos, 2007). SCALEs 
are libraries that provide quantification of the effects that the expression of a specific gene or gene 
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fragment has on a specific phenotypic trait (Lynch et al. 2007). Bonomo et al. (2008) used the SCALEs 
method to quantify several genome-wide growth phenotypes for E. coli libraries cultured under 
inhibitory levels of different substances that targeted metabolic pathways concerning aspartate. Also, 
recently developed TRMR can be used to construct and map genome-wide promoter mutations in E. 
coli and evaluate them simultaneously. On the other hand, gTME enables the creation and isolation of 
polygenic mutants under several conditions (Alper and Stephanopoulos, 2007; Tyo et al. 2007), thus 
facilitating phenotypes that would be difficult to obtain with conventional gene modification techniques. 
This technique has been used to improve E. coli tolerance to ethanol (Alper and Stephanopoulos, 
2007) and shown to be superior to traditional random mutagenesis and selection methods. One of the 
applications investigated in the study was increasing E. coli tolerance to ethanol. The acquired values 
for the doubling time of the strains transformed by gTME were 13-44% lower than those previously 
obtained by serial sub-culturing (Yomano et al. 1998).   
METABOLIC FLUX ANALYSIS 
Metabolic fluxes are probably the best metric to capture the metabolic state of a cell. Flux quantification 
can be performed using a number of approaches, which can be broadly classified into in silico- and in 
vivo-based metabolic flux analysis (isMFA and ivMFA, respectively). One of the most representative 
examples of isMFA is flux balance analysis (Raman and Chandra, 2009), a technique used to construct 
genome-scale metabolic models and assess the metabolic capabilities of the organism of interest. For 
example, Feist et al. (2010) reported the use of isMFA to evaluate the production potential for growth-
coupled products of E. coli. A recent development in this area is the introduction of the OptForce 
procedure (Ranganathan et al. 2010), which identifies all possible engineering interventions by 
classifying reactions in the metabolic model depending upon whether their flux values must increase, 
decrease or become equal to zero to meet a pre-specified overproduction target. The OptForce 
framework was validated by indentifying non-intuitive engineering strategies for succinate production in 
E. coli. An updated genome-scale network reconstruction of E. coli was also recently reported, 
demonstrating how it can be used to discover non-annotated genes in all strains sequenced to date 
(Orth et al. 2011).  
One of the most widely used versions of ivMFA is a technique known as metabolite balancing, in which 
intracellular fluxes are estimated based on a stoichiometric model and extracellular measurements 
(Stephanopoulos et al. 1998; Klapa et al. 1999). This technique is based on mass balances around 
intracellular metabolites (which are considered in pseudo-steady-state) with the measurements of 
extracellular fluxes acting as constraints for flux calculation.  
In combination with isMFA, metabolite balancing can provide significant insights into microbial 
metabolism (Murarka et al. 2010a). However, given the small number of extracellular measurements, 
when compared to the number of intracellular fluxes, this technique relies on the incorporation of redox 
(NADH/NADPH) and/or ATP balances as part of the stoichiometric model. This, in turn, can lead to 
incorrect flux estimation due to the incomplete knowledge about pathways involving NADH/NADPH 
and ATP. Another drawback of metabolite balancing is its inability to account for parallel metabolic 
pathways, metabolic cycles, and reversible or bidirectional reactions (Wiechert et al. 2001).  
The use of isotopically labeled substrates (usually with 13C) provides additional constraints to the 
stoichiometric equations used in metabolite balancing, avoiding assumptions about redox and energy 
balances and potentially accounting for parallel pathways, cycles, and reversibility (Klapa et al. 1999). 
This approach is based on feeding an organism with a mixture of a specifically 13C-labeled and a 
naturally abundant version of the same substrate and measuring the 13C enrichments or isotopomer 
distributions in the carbon atoms of different metabolites. The most common metabolites used for this 
purpose are proteinogenic amino acids because they are abundant, stable, and their labeling pattern 
reflects that of precursors metabolites generated in central metabolism. In one approach called 
metabolic flux ratio (MetaFoR) analysis relative local fluxes around a node are obtained from the 
abundances of intact carbon fragments in metabolites (calculated from the 2-D [13C, 1H] NMR data) 
(Fischer and Sauer, 2003; Fischer and Sauer, 2005). Comprehensive 13C-based metabolic flux 
analysis (13C-MFA), on the other hand, is achieved through a modeling approach that requires 
information on the metabolic network, labeling patterns of amino acids, and extracellular fluxes. This 
information is combined in an error function that accounts for the average difference between 
measured and simulated labeling patterns. An optimization procedure is then followed to solve for 
intracellular fluxes that minimize this error function (Klapa et al. 1999; Tang et al. 2009). 13C-MFA has 
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been extensively used to characterize the fermentative metabolism of E. coli (Murarka et al. 2010b; 
Choudhary et al. 2011).  
An excellent example of the value of different MFA approaches to the design and implementation of 
ME strategies was recently reported on an integrated computational and experimental study for 
overproducing fatty acids in E. coli (Ranganathan et al. 2012). The OptForce procedure was used for 
suggesting and prioritizing genetic manipulations that could support overproduction of fatty acids of 
different chain lengths (C6-C16) starting with wild-type E. coli. When interventions suggested by 
OptForce were implemented, the engineered strain produced 1.70 g/L of C(14-16) fatty acids in minimal 
medium at a yield of 0.14 g fatty acid/g glucose.  
 
 
 
 
 
 
 
 
 
 
Fig. 1 Interplay between synthesis and analysis of metabolism, the key components of the metabolic 
engineering cycle. Representative approaches for synthesis and analysis are shown.  
Metabolic control analysis 
The identification of metabolic bottlenecks and rate-limiting steps has always been of paramount 
importance for metabolic engineering and Metabolic Control Analysis (MCA) has for long provided a 
framework to conducting such analyses. MCA can be used to elucidate the control structure of a 
metabolic network (Fell and Sauro, 1985). This is achieved through the calculation of flux and 
concentration control coefficients, the former being of special importance because they indicate how a 
relative change in the activity of an enzyme affects the flux of a pathway (Stephanopoulos et al. 1998). 
Such an analysis can identify reactions that control the carbon flux through the pathway and hence 
genes/proteins that need to be manipulated to increase the flux towards the desired product. The MCA 
approach was recently used to conduct a quantitative analysis of the fermentative metabolism of 
glycerol in E. coli, gain a better understanding of glycerol fermentation and identify key targets for 
genetic manipulation that could enhance product synthesis (Cintolesi et al. 2012). The calculated flux 
control coefficients predicted that the glycolytic flux during glycerol fermentation is almost exclusively 
controlled by the enzymes glycerol dehydrogenase (encoded by gldA) and dihydroxyacetone kinase 
(encoded by dhaKLM). In agreement with the MCA findings, overexpression of gldA and dhaKLM led to 
significant increase in glycerol utilization and ethanol synthesis fluxes.  
An MCA-based method, called ORACLE (optimization and risk analysis of complex living entities), has 
also been proposed to calculate control coefficients without the need for a kinetic model (Miskovic and 
Hatzimanikatis, 2010).   
“Omics” analyses 
Advances of the genomic revolution have opened new opportunities for the challenging task of 
assigning biological function to each gene and elucidating the metabolic and regulatory networks that 
operate in a biological system. Functional genomics has then emerged as a new discipline that relates 
Analysis
• Metabolic flux analysis
• Metabolic control analysis
• “Omics” analyses
Synthesis
• Gene “knock-ins/knock-outs”
• Genome engineering
• High-throughput screening
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to “the development and application of high-throughput global (genome-wide or system-wide) 
experimental approaches to assess gene function by making use of the information and reagents 
provided by structural genomics” (Hieter and Boguski, 1997). The field of functional genomics has 
grown exponentially in the last decades, embracing areas such as transcriptomics (mRNAs), 
proteomics (proteins), metabolomics (metabolites), and fluxomics (fluxes), among others. This 
systems-level approach to understand complex metabolic and regulatory networks enables the design 
of more efficient microorganisms for the production of valuable molecules, including biofuels. 
Significant progress in the development of functional genomic tools in recent years has powered the 
elucidation of complex phenotypes and the engineering of new ones for the development of promising 
industrial strains (Stephanopoulos et al. 2004; Zhang et al. 2006). The use of transcriptional profiling 
tools, such as DNA microarrays, allows the study of gene expression by identifying differentially 
expressed genes under different experimental conditions or resulting from certain genetic 
perturbations. However, other functional genomics tools are required to complement transcriptomic 
studies. Proteomics is of special importance because most of the cellular activities are mediated by 
proteins, and is the primary tool used to describe cellular interactions beyond mRNA level (Graham et 
al. 2007). The large-scale quantification and identification of proteins can be achieved by one- or two-
dimensional gel electrophoresis, followed by software aided quantification tools and mass spectrometry 
techniques (Watt et al. 2003), or by gel-free techniques such as liquid chromatography coupled to 
tandem mass spectrometry (LC-MS/MS) and protein isotope labeling (Gevaert et al. 2007). 
Comparative proteomic analyses detect differentially expressed proteins by variations in the intensities 
of labeled protein spots in the gel, under different genetic or environmental conditions. Similar to 
proteins, metabolites are also context-dependent entities whose concentration is directly related to the 
physiological state of the cell (Raamsdonk et al. 2001). Metabolomics makes use of high-throughput 
analyses like Nuclear Magnetic Resonance (NMR), and Gas or Liquid Chromatography coupled to 
Mass Spectrometry (GC-MS, and LC-MS) for the quantification of intra- and extra-cellular small-
molecular-weight metabolites (Buchholz et al. 2002). Metabolic studies also serve as a screening tool 
to investigate the unknown effect of a specific genetic modification on the phenotype of the organism, 
and as a means to describe metabolism kinetics by performing pulse experiments (Buchholz et al. 
2002). 
ENGINEERING OF FERMENTATIVE AND NON-FERMENTATIVE PATHWAYS FOR FUEL 
PRODUCTION IN E. COLI 
The engineering of pathways that convert key intermediates into the fuel of interest is typically the first 
step taken to ensure product synthesis at maximum yield and rate. Both fermentative and biosynthetic 
pathways have been engineered in E. coli for the production of a variety of alcohols, fatty acids and a 
host of novel fuels derived from the fatty acid, polyketide, and isoprenoid biosynthesis pathways, as 
well as engineered ketoacid and reversal of the β-oxidation pathways, among others.  
Engineering of fermentative pathways 
One of the first applications of metabolic engineering was reported about 25 years ago, when the 
laboratory of Lonnie Ingram engineered E. coli to produce ethanol as the primary product of glucose 
fermentation (Ingram et al. 1987). Under fermentative conditions, growth of wild-type E. coli on simple 
sugars, such as glucose and xylose, results in the production of acids (lactic, formic, succinic and 
acetic) and small amounts of ethanol (Sawers and Clark, 2004). To engineer a homoethanologenic 
pathway, Ingram and co-workers (Ingram et al. 1987) transferred the ethanol synthesis pathway from 
Zymomonas mobilis (a two step pathway in which pyruvate decarboxylase (PDC) converts pyruvate 
directly to acetaldehyde and CO2 and alcohol dehydrogense (ADH) then converts acetaldehyde into 
ethanol: Figure 2) to a strain of E. coli containing a mutation in the frd operon (encoding the enzyme 
fumarate reductase, which is responsible for the conversion of fumarate to succinate). These two sets 
of genetic manipulations led to a complete shift of the fermentative metabolism of E. coli from mixed 
acid to homoethanologenic fermentation (Ingram et al. 1987; Ohta et al. 1991) and paved the way for 
the metabolic engineering of E. coli to efficiently synthesize ethanol and a host of fuel molecules.  
While ethanol was the first biofuel to reach commercial production, its incompatibility with current fuel 
infrastructure poses a significant challenge for its widespread adoption. Higher-chain alcohols, on the 
other hand, represent a potential alternative and hence their biological production has been explored. 
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Some of these alcohols are natively produced by a number of Clostridium strains (Chen and Hiu, 1986; 
Jones and Woods, 1986). However, given the lack of genetic capabilities available for the optimization 
of these organisms, the engineering of E. coli was recently investigated with promising results. For 
example, E. coli was engineered to produce isopropanol at levels higher than any seen in naturally 
producing organisms (4.9 g/L) by the expression of the acetone production pathway of Clostridium 
acetobutylicum along with a secondary alcohol dehydrogenase to convert acetone into isopropanol 
(Figure 2) (Hanai et al. 2007). 
 
Fig. 2 Pathways engineered in E. coli for the fermentative production of ethanol, ispropanol, and 1-butanol 
(shown in grey shaded boxes). Broken lines represent multiple reaction steps.  Relevant reactions are 
represented by the name of the genes coding for the enzyme. Non-E. coli genes are noted in parenthesis using the 
following abbreviations: Clostridium acetobutylicum (Ca); Clostridium beijerinckii (Cb); Treponema denticola (Td); 
Zymomonas mobilis (Zm). aceEF-lpdA, pyruvate dehydrogenase multienzyme complex; ackA, acetate kinase; adc, 
acetoacetate dehydrogenase (Ca); adh, secondary alcohol dehydrogenase (Cb); adhB, alcohol dehydrogense (Zm); 
adhE, acetaldehyde/ alcohol dehydrogenase; adhE2, secondary alcohol dehydrogenase (Ca); atoA, atoD, acetyl-
CoA:acetoacetyl-CoA transferase; atoB, acetyl-CoA acyltransferase; bcd, butyryl-CoA dehydrogenase (Ca); crt 
crotonase (Ca); ctfAB, acetoacetyl-CoA transferase (Ca) etfAB, electron transfer flavoprotein (Ca); hbd, β-
hydroxybutyryl-CoA dehydrogenase (Ca); pdc, pyruvate decarboxylase (Zm); pflB, pyruvate formate lyase; pta, 
phosphate acetyltransferase; thl, acetyl-CoA acyltransferase (Ca); ter, trasnenoyl-CoA reductase (Td). 
Abbreviations: 2[H] = NAD(P)H = FADH2; DHAP, dihydroxyacetone-phosphate; Gly-3-P, glyceraldehyde-3-
phosphate; PYR, pyruvate. 
The synthesis of 1-butanol via engineered fermentative pathways has also been reported in E. coli. 
Initial work focused on the transfer of the 1-butanol synthesis portion of the Clostridial Acetone-
Butanol-Ethanol (ABE) pathway into strains of E. coli devoid of native fermentative pathways (Atsumi et 
al. 2008a; Inui et al. 2008) (Figure 2). Expression of native E. coli AtoB (atoB), along with all the 
necessary genes for butanol production from acetyl-CoA (thl, hbd, crt, bcd, etfAB, and adhE2), and 
disruption of native pathways competing with the butanol pathway for acetyl-CoA and NADH (deletion 
of ldhA, adhE, frdBC, pta, and fur) led to a maximum butanol titer of 550 mg/L (Atsumi et al. 2008a). 
Similar levels of 1-butanol production were achieved upon expression of the same pathway from 
polycistronic constructs, along with the expression of formate dehydrogenase (fdh1) from 
Saccharomyces cerevisiae, which increases the availability of reducing equivalents, and 
glyceraldehyde 3-phosphate (gapA) from E. coli to increase glycolytic flux (Nielsen et al. 2009). 
Another study reported the production of 1.2 g/L of 1-butanol after 60 hrs upon expression of the entire 
heterologous pathway from a single plasmid (Inui et al. 2008). 
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While the success of the above-mentioned efforts was limited by the low activity of the foreign pathway 
in E. coli, identification of key limiting steps and use of genes/enzymes not involved in the native 1-
butanol synthesis pathway has recently enabled the efficient synthesis of 1-butanol (Bond-Watts et al. 
2011; Shen et al. 2011). Of particular relevance was the use of a transenoyl-CoA reductase from 
Treponema denticola to replace the clostridial butyryl-CoA dehydrogenase in the conversion of 
crotonyl-CoA to butyryl-CoA (Bond-Watts et al. 2011; Shen et al. 2011). Process-based improvements, 
such as the removal of 1-butanol from the fermentation broth, led to the synthesis of 30 g/L of 1-
butanol (Shen et al. 2011).  
Engineering of non-fermentative pathways 
While fermentative pathways can be exploited for the synthesis of valuable fuel candidates, the use of 
non-fermentative pathways represents an invaluable opportunity to generate “designer” fuels with 
properties that make them compatible with current infrastructure for fuel transportation, storage and 
use. Such pathways include the fatty acid, polyketide, and isoprenoid biosynthesis pathways, as well 
as engineered keto-acid and reversal of the β-oxidation pathways (Figure 3). 
Fuels derived from the fatty acid biosynthesis pathway 
The high-energy content and wide array of chain length and degree of saturation of fatty acids could 
support the synthesis of molecules similar in structure and composition to those currently found in 
petroleum-based fuels. The activated form of fatty acids, thioesters with coenzyme A (fatty acyl-CoAs) 
or acyl carrier protein (fatty acyl-ACPs), are key intermediates in the biosynthesis of fatty acid derived 
fuels (Figure 3). A number of recent reports have shown the potential of engineering the native fatty 
acid biosynthesis pathway in E. coli to produce fatty acids (Lennen et al. 2010; Steen et al. 2010; 
Zhang et al. 2011), fatty esters (Steen et al. 2010), long-chain alcohols (Steen et al. 2010), waxes 
(Steen et al. 2010), hydrocarbons (Lennen et al. 2010; Schirmer et al. 2010), methyl ketones (Park et 
al. 2012), and biodiesel (Steen et al. 2010). 
In an early study, E. coli was engineered to produce fatty esters (biodiesel), fatty alcohols, and waxes 
directly from simple sugars or hemicellulose (Steen et al. 2010). Production of free fatty acids and acyl-
CoAs through the native fatty acid biosynthesis pathway was achieved by eliminating β-oxidation, and 
by overexpressing thioesterases and acyl-CoA ligases. The synthesis of biodiesel, alcohols and wax 
esters was achieved by overexpression of non-native pathways. For example, alcohols were produced 
from fatty acyl-CoAs by overexpressing fatty acyl-CoA reductases, esters by expressing an 
acyltransferase in conjunction with an alcohol-forming pathway, and biodiesel by introducing the 
ethanol pathway shown in Figure 2. 
The synthesis of alkanes, on the other hand, was facilitated by the discovery of an alkane biosynthesis 
pathway from cyanobacteria that consists of an acyl-acyl carrier protein reductase that reduces acyl-
ACPs to fatty aldehydes, which are then decarbonylated to odd-chain alkanes and alkenes by an 
aldehyde decarbonylase (Schirmer et al. 2010). Although the mechanism employed by the 
decarbonylase is still under investigation (Das et al. 2011; Li et al. 2011), the expression of the two-
step pathway in E. coli produced C13-C17 mixtures of alkanes and alkenes (Schirmer et al. 2010). 
Fuels derived from the isoprenoid biosynthesis pathway  
While isoprenoids are naturally synthesized by plants, animals, and bacteria, and used for their 
pharmaceutical and nutritional value (Rude and Schirmer, 2009), only recently there has been an 
interest in producing isoprenoid-derived biofuels. Two different pathways have been utilized to 
overproduce isoprenoids from the precursor metabolites isopentenyl pyrophosphate (IPP) and 
dimethylallyl pyrophosphate (DMAPP) (Figure 3). The mevalonate pathway generates the 
aforementioned precursors using acetyl-CoA, while the methylerythritol phosphate pathway produces 
them from glyceraldehyde-3-phosphate (G3P) and pyruvate (Dewick, 2002). Diterpene precursors 
geranyl pyrophosphate (GPP), farnesyl phosphate (FPP), and geranylgeranyl pyrophosphate (GGPP) 
are then generated from IPP and DMAPP through the action of prenyltransferases (Rude and 
Schirmer, 2009). Isoprenoid alcohols and olefins, which are fuel molecules, can be synthesized from 
IPP, GPP, FPP, or GGPP through the action of phosphatases, pyrophosphatases, and terpene 
synthases (Christianson, 2008; Rude and Schirmer, 2009). For example, isopentenol was produced in 
an E. coli strain engineered to overproduce IPP and DMAPP via the mevalonate pathway, in 
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combination with the isopentenol biosynthetic pathway from Bacullis subtilis (yhfR and nudF) (Martin et 
al. 2003; Withers et al. 2007).  
More recently, E. coli has been engineered for the production of farnesol (Wang et al. 2010), farnesene 
(Renninger and McPhee, 2008), pinene (Reiling et al. 2004), limonene (Carter et al. 2003), and 
bisabolene (Peralta-Yahya et al. 2011). In the case of farnesol, heterologous mevalonate pathways 
and FPP synthase were over expressed in combination with endogenous phosphatases for FPP 
hydrolysis (Wang et al. 2010). Bisabolene, on the other hand, was produced at levels approaching 1 
g/L by expressing in E. coli a codon-optimized bisabolene synthase from Abies grandis in combination 
with an optimized heterologous mevalonate pathway (Peralta-Yahya et al. 2011). 
Fuels derived from amino acid/ketoacid biosynthesis pathways 
The native amino acid biosynthetic pathways in E. coli can be harnessed to generate 2-ketoacids, 
which serve as precursors for higher chain alcohol production through a two step synthetic pathway 
that mimics the Ehrlich degradation pathway: i.e. conversion of 2-ketoacids to an alcohol, with an 
aldehyde as an intermediate, through the action of a 2-ketoacid decarboxylase (KDC) and an alcohol 
dehydrogenase (ADH) (Figure 3) (Atsumi and Liao, 2008b). A 2-ketoacid decarboxylase from 
Lactococcus lactis and an alcohol dehydrogenase Adh2 from S. cerevisiae exhibited broad substrate 
activity toward a number of 2-ketoacids and enabled the production of 1-propanol, isobutanol, 1-
butanol, 2-methyl-1-butanol, 3-methyl-1-butanol, and 2-phenylethanol in an engineered E. coli (Atsumi 
et al. 2008b) (Figure 3). The yield and productivity of these alcohols was improved by increasing the 
production of the 2-ketoacid intermediates using different strategies. For example, expression of als (B. 
subtilis) and ilvCD (E. coli) to generate 2-ketoisovalerate, combined with the expression of the 
aforementioned KDC and ADH, led to an engineered strain able to produce ~22 g/L of isobutanol after 
110 hrs at a yield of 86% of the theoretical maximum (Atsumi et al. 2008b). Similar strategies were 
used to demonstrate the efficient synthesis of 1-propanol and 1-butanol, observing the production of 
3.5 g/L of 1-propanol and ~500 mg/L of 1-butanol after 92 hrs (Atsumi and Liao, 2008a; Shen and Liao, 
2008). These natural amino acid pathways were also utilized to produce the 5-carbon alcohols, 2-
methyl-1-butanol (2MB) and 3-methyl-1-butanol (3MB) (Figure 3) (Cann and Liao 2008; Connor and 
Liao 2008; Connor and Liao, 2009). 
The above strategy, based on the use of the amino acid biosynthetic pathways, has also been 
exploited to produce non-natural 5 to 8 carbon higher alcohols derived from isoleucine biosynthesis. To 
this end, the product chain length of LeuA and substrate chain length of 2-ketoacid decarboxylase 
(KIVD) was expanded to enable the synthesis of non-natural ketoacids, which were then converted to 
higher chain alcohols such as 1-pentanol, 1-hexanol, (S)-3-methyl-1-pentanol, 4-methyl-1-pentanol, 
(S)-4-methyl-1-hexanol, and (S)-5-methyl-heptanol (Zhang et al. 2008).     
Fuels derived from an engineered β-oxidation pathway 
A variation of the β-oxidation cycle has been engineered to work in the reverse biosynthetic direction 
(as opposed to its natural catabolic direction) in order to produce fuels and chemicals from different 
carbon sources (Figure 3) (Dellomonaco et al. 2011; Clomburg et al. 2012). In the earlier report 
(Dellomonaco et al. 2011), a system-level approach was used in which several points for regulation of 
the β-oxidation cycle, namely fad, ato, crp, and arcA, were engineered. These modifications, in 
combination with the overexpression of endogenous dehydrogenases and thioesterases, enabled the 
synthesis of n-alcohols, FAs, and carboxylic 3-hydroxy-, 3-keto-, and trans-∆
2
-carboxylic acids 
(Dellomonaco et al. 2011). In addition, the deletion of the competing pathways for ethanol (adhE), 
acetate (pta), and succinate (frdA) helped minimizing the formation of by-products, while the 
expression of selected termination enzymes enabled the production of a variety of β-oxidation cycle 
intermediates. The introduction of the engineered reversal of the β-oxidation cycle opened many 
opportunities for engineering E. coli metabolism for the production of fuels and chemicals in an ATP-
independent and efficient manner, but given the implications of modifying major regulators in the cell it 
could be difficult to completely elucidate and understand the responsible genes/proteins. To address 
these issues, a more recent study presented in vitro kinetic characterization of the functional units in 
the pathway and used this information to guide a synthetic biology approach to assemble the pre-
defined components of the reversed β-oxidation pathway in vivo conditions and to enable production of 
a variety of carboxylic acids with the combination of different thioesterases (Clomburg et al. 2012). A 
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functional equivalent of the β-oxidation reversal that does not rely on β-oxidation enzymes, has also 
been reported (Dekishima et al. 2011; Machado et al. 2012). 
 
Fig. 3 Non-fermentative routes for the production of alcohols via the ketoacid pathway (dotted line box with 
grey shade), fatty acid- and β-oxidation reversal-derived fuels (solid line box with no shade), and 
isoprenoid-derived biofuels (solid line box with grey shade) in E. coli. Broken lines represent multiple reaction 
steps.  Relevant reactions are represented by the name of the genes coding for the enzyme. Non-E. coli genes are 
noted in parenthesis using the following abbreviations: Acinetobacter calcoaceticus (Ac); Arabidopsis thaliana (At); 
Bacillus subtilis (Bs); Clostridium acetobutylicum (Ca); Corynebacterium glutamicum (Cg); Euglena gracilis (Eg); 
Lactococcus lactis (Ll); Methanococcus jannaschii (Mj); Saccharomyces cerevisiae (Sc); Stenotrophomonas 
maltophilia, (Sm). accABCD, acetyl-CoA carboxylase; acr1, acyl-CoA reductase (Ac); ADH2, alcohol 
dehydrogenase (Sc); adhE2, alcohol dehydrogenase (Ca); atfA, acyltransferase (Ab); atoB/yqeF/fadA, thiolase; 
betA/eutG/yiaY, alcohol dehydrogenase; CER4, fatty acyl-CoA reductase (At); cimA, citramalate synthase (Mj); dxr, 
1-deoxy-D-xylulose 5-phosphate reductoisomerase;  dxs, 1-deoxy-D-xylulose 5-phosphate synthase; ERG12, 
mevalonate kinase (Sc); ERG8, phosphomevalonate kinase (Sc); fabA, hydroxydecanoyl-ACP dehydrase; fabB, 
ketoacyl-ACP synthase I; fabD, malonyl-CoA-ACP transacylase; fabF, ketoacyl-ACP synthase II; fabG, ketoacyl-
ACP reductase; fabI, enoyl-ACP reductase; fabZ, hydroxyacyl-ACP dehydratase; fadD, acyl-CoA synthetase; fadB, 
hydroxyacyl-CoA dehydrogenase & enoyl-CoA hydratase; HMGS, 3-hydroxy-3-methylglutaryl-CoA synthase (Sc); 
idi, isopentenylpyrophosphate isomerase; ispD, 4-diphosphocytidyl-2-methylerythritol synthase; ispE, 4-
diphosphocytidyl-2-methylerythritol kinase; ispF, 2-methylerythritol 2,4-cyclodiphosphate synthase; ispG, 1-hydroxy-
2-methyl-2-(E)-butenyl 4-diphosphate synthase; ispH, 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate reductase; 
kivd, ketoisovalerate decarboxylase (Ll); MVD1, mevalonate pyrophosphate decarboxylase (Sc); nudF, prenyl 
phosphatase (Bs); ter, trasnenoyl-CoA reductase (Eg); tHMGR, truncated 3-hydroxy-3-methylglutaryl-CoA 
reductase (Sc); ydiO, enoyl-CoA reductase; † represents a number of endogenous acyl-CoA and acyl-ACP 
thioesterases; ‡ represents numerous reactions leading to the formation of a wide range of isoprenoids. 
Abbreviations: Ac-CoA, acetyl-CoA; ACP, acyl carrier protein; CoA, coenzyme A; DMAPP, dimethylallyl 
pyrophosphate; FAEE, fatty acid ethyl ester; Gly-3-P, glyceraldehyde-3-phosphate; IPP, isopentenyl pyrophosphate; 
PEP, phosphoenolpyruvate. 
The β-oxidation pathway has also been exploited for the production of methyl ketones in E. coli (Goh et 
al. 2012). The authors used a strategy in which synthesis of methyl-ketones is achieved by 
overexpression of acyl-CoA oxidase to generate β-ketoacyl-CoA, which is then hydrolyzed by an 
endogenous thioesterase (FadM) and the resulting ketoacid decarboxylated to C11-C15 methyl ketones 
at a titer of 380 mg/L and 58% of the maximum theoretical yield. 
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ENGINEERED PATHWAYS THAT ENABLE THE USE OF ALTERNATIVE FEEDSTOCKS FOR 
FUEL PRODUCTION IN E. COLI 
The engineering efforts discussed above mainly focused on engineering pathways that convert 
metabolites in central metabolic pathways to the target fuel molecule. Another important consideration 
is the use of more efficient substrates that can lead to higher product yields. Two abundant substrates, 
glycerol and fatty acids, can be considered in this category.  
The reduced nature of carbon atoms in glycerol and fatty acids provides significant advantages for the 
production of fuels, such as alcohols, alkanes, and others, when compared to their production from 
sugars (Clomburg and González, 2013). For example, fermentative metabolism of glycerol leads to the 
synthesis of ethanol as the preferable product due to the fact that ethanol synthesis from glycerol 
represents an NADH balanced pathway that produces ATP via substrate level phosphorylation. 
Metabolic engineering strategies have been implemented to minimize by-product formation through the 
disruption of genes encoding fumarate reductase (frdA) and phosphotransacetylase (pta), key 
enzymes in the synthesis of succinate and acetate, respectively (Yazdani and González, 2008). The 
resulting strain co-produced ethanol and hydrogen in nearly equimolar amounts approaching the 
maximum theoretical yield of 1 mol each of ethanol and hydrogen per mol of glycerol fermented. Using 
a similar strategy, with the additional disruption of the enzyme responsible for the oxidation of formate 
into H2 and CO2, the efficient co-production of ethanol and formate was achieved (Yazdani and 
González, 2008). While promising, strains reported in that study (Yazdani and González, 2008) 
required rich supplementation in the form of tryptone to be able to produce ethanol and co-products 
formate or hydrogen. Microaerobic conditions were then used as a means to eliminate the need for rich 
nutrients while still taking advantage of the higher degree of reduction of glycerol for product synthesis 
(Durnin et al. 2009). In another study, elementary mode analysis was used to design an E. coli strain 
for the conversion of glycerol into ethanol (Trinh and Srienc, 2009). A coupling between cell growth and 
ethanol production enabled metabolic evolution of the designed strain to convert 40 g/L glycerol to 
ethanol at 90% of the theoretical yield. 
E. coli has also been engineered for the production of ethanol, isopropanol, and 1-butanol from fatty 
acid feedstocks, resulting in product yields much higher than the theoretical maximum obtained from 
sugars (Dellomonaco et al. 2010). In order to produce ethanol under the respiro-fermentative 
conditions required for fatty acid utilization, an aerotolerant mutant of alcohol dehydrogenase (encoded 
by adhE) was constructed. Overexpression of AdhE* from an oxygen-independent promoter in a strain 
engineered for efficient and complete degradation of fatty acids resulted in the production of ethanol 
with yields two-times greater than the theoretical maximum value than can be achieved with the use of 
lignocellulosic sugars (Dellomonaco et al. 2010). In the same study, E. coli was also engineered to 
produce isopropanol and 1-butanol from fatty acids through the expression of the fermentative 
pathways for the synthesis of these molecules from acetyl-CoA shown in Figure 2 and described in 
previous sections. 
CONCLUDING REMARKS 
As the above sections show, metabolic engineering has become an established discipline and enabled 
the development of microbial systems for fuel production from a number of renewable feedstocks. 
Advancements in the field of synthetic biology are key to current and future success. In addition, the 
use of system biology tools such as genomics, transcriptomics, proteomics, metabolomics, and 
fluxomics will facilitate the design, characterization and integration of new metabolic pathways for 
biofuel production. The development of new strategies and tools from these fields will support further 
increases in yield, titer, and productivity of existing and new biofuel molecules from various feedstocks. 
This, in turn, represents a promising avenue for the viable industrial production of renewable fuels. 
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